UK markets close in 11 minutes

The Chemours Company (CC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
27.21-0.70 (-2.51%)
As of 11:19AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.33B
Enterprise value 6.99B
Trailing P/E 5.23
Forward P/E 4.88
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.66
Price/book (mrq)3.57
Enterprise value/revenue 1.01
Enterprise value/EBITDA 4.62

Trading information

Stock price history

Beta (5Y monthly) 1.81
52-week change 3-8.37%
S&P500 52-week change 3-14.01%
52-week high 344.95
52-week low 322.56
50-day moving average 332.92
200-day moving average 333.53

Share statistics

Avg vol (3-month) 31.49M
Avg vol (10-day) 32.94M
Shares outstanding 5155.14M
Implied shares outstanding 6N/A
Float 8153.23M
% held by insiders 11.03%
% held by institutions 174.58%
Shares short (14 Sept 2022) 44.45M
Short ratio (14 Sept 2022) 44.4
Short % of float (14 Sept 2022) 43.24%
Short % of shares outstanding (14 Sept 2022) 42.87%
Shares short (prior month 14 Aug 2022) 43.89M

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 44.06%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 33.58%
5-year average dividend yield 43.59
Payout ratio 418.73%
Dividend date 314 Sept 2022
Ex-dividend date 411 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 12.71%
Operating margin (ttm)14.71%

Management effectiveness

Return on assets (ttm)8.38%
Return on equity (ttm)83.31%

Income statement

Revenue (ttm)6.93B
Revenue per share (ttm)43.06
Quarterly revenue growth (yoy)15.70%
Gross profit (ttm)1.38B
EBITDA 1.32B
Net income avi to common (ttm)881M
Diluted EPS (ttm)5.34
Quarterly earnings growth (yoy)204.50%

Balance sheet

Total cash (mrq)1.25B
Total cash per share (mrq)8.04
Total debt (mrq)3.91B
Total debt/equity (mrq)321.81
Current ratio (mrq)1.91
Book value per share (mrq)7.80

Cash flow statement

Operating cash flow (ttm)818M
Levered free cash flow (ttm)321.25M